Drug reformulation firm iCeutica raises $2.6M
Drug reformulation company iCeutica has raised nearly $2.6 million, according to a Securities and Exchange Commission filing. iCeutica uses its “SoluMatrix” technology to reformulate drugs for pharmaceutical clients. Companies typically reformulate drugs in order to protect patents that are in danger of expiring or to introduce a new delivery method, such as administering the drugs […]